-
CMAJ : Canadian Medical Association... Nov 2021
Topics: Alzheimer Disease; Antibodies, Monoclonal, Humanized; Canada; Drug Approval; Drug Costs; Humans; Immunologic Factors; Infusions, Intravenous; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration
PubMed: 34725122
DOI: 10.1503/cmaj.211134-f -
CMAJ : Canadian Medical Association... Jan 2024
Topics: Humans; Alzheimer Disease; Canada; Antibodies, Monoclonal, Humanized
PubMed: 38286492
DOI: 10.1503/cmaj.230595-f -
Science Advances Apr 2023Energy-efficient, healthy lighting is vital for human beings. Incandescent lighting provides high-fidelity color rendering and ergonomic visual comfort yet is phased out...
Energy-efficient, healthy lighting is vital for human beings. Incandescent lighting provides high-fidelity color rendering and ergonomic visual comfort yet is phased out owing to low luminous efficacy (15 lumens per watt) and poor lifetime (2000 hours). Here, we propose and experimentally realize a photon-recycling incandescent lighting device (PRILD) with a luminous efficacy of 173.6 lumens per watt (efficiency of 25.4%) at a power density of 277 watts per square centimeter, a color rendering index (CRI) of 96, and a LT70-rated lifetime of >60,000 hours. The PRILD uses a machine learning-designed 637-nm-thick visible-transparent infrared-reflective filter and a Janus carbon nanotube/hexagonal boron nitride filament to recycle 92% of the infrared radiation. The PRILD has higher luminous efficacy, CRI, and lifetime compared with solid-state lighting and thus is promising for high-power density lighting.
PubMed: 37043569
DOI: 10.1126/sciadv.adf3737 -
Seminars in Plastic Surgery Nov 2022
PubMed: 36544810
DOI: 10.1055/s-0042-1758694 -
Stroke May 2023
PubMed: 37094029
DOI: 10.1161/STROKEAHA.123.042506 -
Journal of the Royal Society of Medicine Feb 1981
Topics: Community Psychiatry; Epidemiology; History, 20th Century; United Kingdom
PubMed: 7009862
DOI: 10.1177/014107688107400202 -
EMBO Reports May 2024The article processing charges associated with open-access publishing are unaffordable for some scientists. One solution is to break the APC down into its component... (Review)
Review
The article processing charges associated with open-access publishing are unaffordable for some scientists. One solution is to break the APC down into its component parts, enabling scientists to spread the costs over multiple providers and several years. [Image: see text]
Topics: Humans; Animals
PubMed: 38684908
DOI: 10.1038/s44319-024-00138-1 -
Current Oncology (Toronto, Ont.) Jun 2019
Topics: Humans; Inventions; Palliative Care
PubMed: 31285659
DOI: 10.3747/co.26.4803 -
British Dental Journal Jul 2020
PubMed: 32710023
DOI: 10.1038/s41415-020-1935-6